Halozyme Therapeutics HALO Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's price / sales?
- Halozyme Therapeutics (HALO) reported price / sales of 5.1× in Q1 2026.
- How has Halozyme Therapeutics's price / sales changed year-over-year?
- Halozyme Therapeutics's price / sales decreased by 30.2% year-over-year, from 7.3× to 5.1×.
- What is the long-term trend for Halozyme Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's price / sales has grown at a -23.8% compound annual growth rate (CAGR), from 22× to 5.7×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.